As of Jun 29, 2018 Zosano Pharma Corporation (NASDAQ:ZSAN) Sellers Reduced Their Shorts By 43.02%

June 29, 2018 - By Eric Painter

It was registered a decrease on Zosano Pharma Corporation (NASDAQ:ZSAN)’s shorted shares with 43.02%. FINRA issued shorted shares of ZSAN’s total 924,200 shares. That’s 43.02% down from 1.62M shares. 2 days will cost ZSAN with 523,600 average volume to recover its previous position. 2.89% is Zosano Pharma Corporation float short.

Ticker’s shares touched $4.06 during the last trading session after 2.01% change.Currently Zosano Pharma Corporation is downtrending after 85.30% change in last June 29, 2017. ZSAN has 185,578 shares volume. ZSAN underperformed the S&P500 by 97.87%.

Zosano Pharma Corporation, a clinical stage pharmaceutical company, develops a proprietary intracutaneous delivery system to administer drugs through the skin for rapid symptom relief to patients.The firm is valued at $48.61 million. The Company’s lead product candidate is M207, a proprietary formulation of zolmitriptan used for the treatment of migraine.Currently it has negative earnings.

For more Zosano Pharma Corporation (NASDAQ:ZSAN) news published recently go to: Streetinsider.com, Benzinga.com, Benzinga.com, Globenewswire.com or Benzinga.com. The titles are as follows: “Pre-Open Movers 06/28: (DRRX) (ZSAN) (CAVM) Higher; (ASNS) (PIR) (WBA) Lower (more…)” published on June 28, 2018, “48 Biggest Movers From Yesterday” on June 29, 2018, “20 Stocks Moving In Thursday’s Pre-Market Session” with a publish date: June 28, 2018, “Market Trends Toward New Normal in ANSYS, Pearson, Qualys, HB Fuller, Cabot Microelectronics, and Zosano …” and the last “60 Biggest Movers From Yesterday” with publication date: June 19, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: